I'm a PostDoc in the Laboratory of Lipoprotein, Immunity, and Atherosclerosis headed by Prof. Norata in the Department of Pharmacological and Biomolecular Sciences at the University of Milan, Italy. My research interests in the laboratory of Professor Norata is the pharmacology of the cardiovascular system, specifically the role of PCSK9 as a regulatory protein of glucose and lipid metabolism. Recently, we moved our attention to the impact of mitochondrial metabolism and dynamics in the hepatic sterol metabolism and therefore in the development of dyslipidemia and atherosclerosis.

My research focuses on understanding how innate immune cells contributes to cardiovascular diseases. I have great experience in dealing with low-input and single-cell multi-omics sequencing. I am also researching hematopoiesis using gene editing tools and inducible pluripotent stem cells (iPSC). In addition to wet lab-based research, I am proficient in exploiting bioinformatic tools to integrate datasets from various sources, identifying potential diagnostic or therapeutic markers, and visualizing scientific data. With pharmacy and medical affairs background, I am keen to design implementable experiments to approach clinical questions.

I am a PhD candidate at the division of BioTherapeutics at the Leiden Academic Centre for Drug Research (LACDR), Leiden University. Elucidating immune cell mechanisms contributing to atherosclerosis and finding ways to stabilize atherosclerotic plaques are the main aims of our group.

Post-doctoral researcher at the Leiden Academic Centre for Drug Research (LACDR), Leiden University. As a basic and translational scientist, she aims to elucidate how the immune system, in particular T cells, affects atherosclerosis progression by means of single-cell multi-omic approaches.